[Antitumor antibiotics]. 2015

Takao Suzuki

UI MeSH Term Description Entries
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D001761 Bleomycin A complex of related glycopeptide antibiotics from Streptomyces verticillus consisting of bleomycin A2 and B2. It inhibits DNA metabolism and is used as an antineoplastic, especially for solid tumors. BLEO-cell,Blanoxan,Blenoxane,Bleolem,Bleomicina,Bleomycin A(2),Bleomycin A2,Bleomycin B(2),Bleomycin B2,Bleomycin Sulfate,Bleomycins,Bleomycinum Mack,Bléomycine Bellon,BLEO cell,BLEOcell,Bellon, Bléomycine,Mack, Bleomycinum,Sulfate, Bleomycin
D003609 Dactinomycin A compound composed of a two CYCLIC PEPTIDES attached to a phenoxazine that is derived from STREPTOMYCES parvullus. It binds to DNA and inhibits RNA synthesis (transcription), with chain elongation more sensitive than initiation, termination, or release. As a result of impaired mRNA production, protein synthesis also declines after dactinomycin therapy. (From AMA Drug Evaluations Annual, 1993, p2015) Actinomycin,Actinomycin D,Meractinomycin,Cosmegen,Cosmegen Lyovac,Lyovac-Cosmegen,Lyovac Cosmegen,Lyovac, Cosmegen,LyovacCosmegen
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000903 Antibiotics, Antineoplastic Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. Antineoplastic Antibiotics,Cytotoxic Antibiotics,Antibiotics, Cytotoxic
D016685 Mitomycin An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis. Mitomycin C,Ametycine,Mitocin-C,Mitomycin-C,Mutamycin,NSC-26980,Mitocin C,MitocinC,NSC 26980,NSC26980
D017663 Peplomycin An antineoplastic agent derived from BLEOMYCIN. Pepleomycin,NK-631,Peplomycin Sulfate,Peplomycin Sulfate (1:1),NK 631,NK631,Sulfate, Peplomycin

Related Publications

Takao Suzuki
December 1989, Current opinion in oncology,
Takao Suzuki
January 1961, Voprosy onkologii,
Takao Suzuki
April 1961, Antibiotics & chemotherapy (Northfield, Ill.),
Takao Suzuki
January 1974, Postepy higieny i medycyny doswiadczalnej,
Takao Suzuki
June 1981, The Journal of antibiotics,
Takao Suzuki
January 1991, Critical reviews in oncology/hematology,
Takao Suzuki
March 1986, Gan to kagaku ryoho. Cancer & chemotherapy,
Takao Suzuki
January 1959, Acta - Unio Internationalis Contra Cancrum,
Takao Suzuki
January 1959, Acta - Unio Internationalis Contra Cancrum,
Takao Suzuki
August 1969, American journal of clinical pathology,
Copied contents to your clipboard!